Endologix Reports Results for the Second Quarter 2016

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/14/2026

1. DPZ
2. BAC
3. NVDA
4. UNH
5. ORCL
6. DVLT
7. LQDA
8. META
9. VSTM
10. GS

Go back to Endologix Reports Results for the Second Quarter 2016

RBC Capital Downgrades Endologix (ELGX) to Sector Perform

August 3, 2016 6:45 AM EDT

RBC Capital downgraded Endologix (NASDAQ: ELGX) from Outperform to Sector Perform with a price target of $12.00 (from $17.00).

For an analyst ratings summary and ratings history on Endologix click here. For more ratings news on Endologix click here.

Shares of Endologix closed at $13.75 yesterday.

... More

Endologix (ELGX) Tops Q2 EPS by 7c, Bumps Outlook

August 2, 2016 4:36 PM EDT

Endologix (NASDAQ: ELGX) reported Q2 EPS of ($0.13), $0.07 better than the analyst estimate of ($0.20). Revenue for the quarter came in at $51 million versus the consensus estimate of $46.3 million.

John McDermott, Endologix Chairman and Chief Executive Officer, said, We continue to deliver solid revenue growth above expectations and are very pleased with the TriVascular mergerintegration. Our revenue performance in the second quarter was driven by strong growth with Nellix in international markets, including the... More